IRIDEX Corporation (IRIX)
USD 0.88
(-7.25%)
USD 0.88
(-7.25%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -9.57 Million USD | -26.81% |
| 2022 | -7.54 Million USD | -44.44% |
| 2021 | -5.22 Million USD | 17.44% |
| 2020 | -6.32 Million USD | 28.19% |
| 2019 | -8.81 Million USD | 31.22% |
| 2018 | -12.81 Million USD | 0.42% |
| 2017 | -12.86 Million USD | -9.85% |
| 2016 | -11.71 Million USD | -2571.1% |
| 2015 | 474 Thousand USD | -95.28% |
| 2014 | 10.03 Million USD | 349.93% |
| 2013 | 2.23 Million USD | 55.15% |
| 2012 | 1.43 Million USD | -44.9% |
| 2011 | 2.61 Million USD | -14.31% |
| 2010 | 3.04 Million USD | 17.83% |
| 2009 | 2.58 Million USD | 135.07% |
| 2008 | -7.37 Million USD | 66.91% |
| 2007 | -22.27 Million USD | -287.14% |
| 2006 | -5.75 Million USD | -444.28% |
| 2005 | 1.67 Million USD | 515.67% |
| 2004 | -402 Thousand USD | -208.36% |
| 2003 | 371 Thousand USD | 147.33% |
| 2002 | 150 Thousand USD | 111.78% |
| 2001 | -1.27 Million USD | -152.69% |
| 2000 | 2.41 Million USD | 49.32% |
| 1999 | 1.61 Million USD | -4.82% |
| 1998 | 1.7 Million USD | -19.05% |
| 1997 | 2.1 Million USD | 110.0% |
| 1996 | 1 Million USD | 0.0% |
| 1995 | 1 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -3.46 Million USD | -17.03% |
| 2024 Q2 | -2.67 Million USD | 22.66% |
| 2023 Q3 | -1.75 Million USD | 36.59% |
| 2023 Q1 | -2.09 Million USD | -82.06% |
| 2023 FY | -9.57 Million USD | -26.81% |
| 2023 Q4 | -2.96 Million USD | -68.76% |
| 2023 Q2 | -2.76 Million USD | -32.34% |
| 2022 FY | -7.54 Million USD | -44.44% |
| 2022 Q4 | -1.14 Million USD | 35.03% |
| 2022 Q3 | -1.76 Million USD | 21.15% |
| 2022 Q1 | -2.39 Million USD | 2.13% |
| 2022 Q2 | -2.24 Million USD | 6.27% |
| 2021 Q4 | -2.44 Million USD | -12.84% |
| 2021 FY | -5.22 Million USD | 17.44% |
| 2021 Q1 | -2.01 Million USD | -1022.91% |
| 2021 Q2 | 1.39 Million USD | 169.3% |
| 2021 Q3 | -2.16 Million USD | -255.42% |
| 2020 Q1 | -1.65 Million USD | -5.77% |
| 2020 Q2 | -2.78 Million USD | -68.38% |
| 2020 Q3 | -1.71 Million USD | 38.17% |
| 2020 Q4 | -179 Thousand USD | 89.59% |
| 2020 FY | -6.32 Million USD | 28.19% |
| 2019 Q2 | -2.41 Million USD | 20.64% |
| 2019 FY | -8.81 Million USD | 31.22% |
| 2019 Q4 | -1.56 Million USD | 12.55% |
| 2019 Q1 | -3.04 Million USD | -6.72% |
| 2019 Q3 | -1.78 Million USD | 26.21% |
| 2018 Q1 | -3.6 Million USD | 30.11% |
| 2018 Q2 | -3.28 Million USD | 8.96% |
| 2018 Q3 | -3.07 Million USD | 6.28% |
| 2018 Q4 | -2.85 Million USD | 7.09% |
| 2018 FY | -12.81 Million USD | 0.42% |
| 2017 Q1 | -1.86 Million USD | 82.75% |
| 2017 Q2 | -2.75 Million USD | -47.37% |
| 2017 Q4 | -5.15 Million USD | -66.51% |
| 2017 Q3 | -3.09 Million USD | -12.58% |
| 2017 FY | -12.86 Million USD | -9.85% |
| 2016 Q1 | 101 Thousand USD | -76.94% |
| 2016 Q2 | -328 Thousand USD | -424.75% |
| 2016 FY | -11.71 Million USD | -2571.1% |
| 2016 Q4 | -10.81 Million USD | -1511.77% |
| 2016 Q3 | -671 Thousand USD | -104.57% |
| 2015 FY | 474 Thousand USD | -95.28% |
| 2015 Q2 | -652 Thousand USD | -365.04% |
| 2015 Q1 | 246 Thousand USD | -97.19% |
| 2015 Q4 | 438 Thousand USD | -0.9% |
| 2015 Q3 | 442 Thousand USD | 167.79% |
| 2014 FY | 10.03 Million USD | 349.93% |
| 2014 Q1 | 487 Thousand USD | 18.2% |
| 2014 Q2 | 297 Thousand USD | -39.01% |
| 2014 Q3 | 490 Thousand USD | 64.98% |
| 2014 Q4 | 8.76 Million USD | 1688.57% |
| 2013 Q4 | 412 Thousand USD | -22.26% |
| 2013 Q3 | 530 Thousand USD | 27.71% |
| 2013 Q2 | 415 Thousand USD | -52.52% |
| 2013 Q1 | 874 Thousand USD | 261.16% |
| 2013 FY | 2.23 Million USD | 55.15% |
| 2012 FY | 1.43 Million USD | -44.9% |
| 2012 Q4 | 242 Thousand USD | 132.48% |
| 2012 Q3 | -745 Thousand USD | -321.73% |
| 2012 Q2 | 336 Thousand USD | -79.07% |
| 2012 Q1 | 1.6 Million USD | 104.2% |
| 2011 Q4 | 786 Thousand USD | 125.21% |
| 2011 Q1 | 566 Thousand USD | -32.38% |
| 2011 Q2 | 909 Thousand USD | 60.6% |
| 2011 FY | 2.61 Million USD | -14.31% |
| 2011 Q3 | 349 Thousand USD | -61.61% |
| 2010 FY | 3.04 Million USD | 17.83% |
| 2010 Q4 | 837 Thousand USD | -8.02% |
| 2010 Q2 | 814 Thousand USD | 67.84% |
| 2010 Q3 | 910 Thousand USD | 11.79% |
| 2010 Q1 | 485 Thousand USD | -6.19% |
| 2009 FY | 2.58 Million USD | 135.07% |
| 2009 Q4 | 517 Thousand USD | -19.97% |
| 2009 Q3 | 646 Thousand USD | -46.08% |
| 2009 Q1 | 224 Thousand USD | 103.44% |
| 2009 Q2 | 1.19 Million USD | 434.82% |
| 2008 Q2 | 275 Thousand USD | 130.83% |
| 2008 Q4 | -6.5 Million USD | -2511.65% |
| 2008 Q3 | -249 Thousand USD | -190.55% |
| 2008 FY | -7.37 Million USD | 66.91% |
| 2008 Q1 | -892 Thousand USD | 94.34% |
| 2007 Q1 | -4.92 Million USD | -30.4% |
| 2007 FY | -22.27 Million USD | -287.14% |
| 2007 Q4 | -15.77 Million USD | -1173.91% |
| 2007 Q3 | -1.23 Million USD | -260.93% |
| 2007 Q2 | -343 Thousand USD | 93.03% |
| 2006 FY | -5.75 Million USD | -444.28% |
| 2006 Q2 | -534 Thousand USD | -102.27% |
| 2006 Q3 | -1.14 Million USD | -114.04% |
| 2006 Q1 | -264 Thousand USD | -169.11% |
| 2006 Q4 | -3.77 Million USD | -230.1% |
| 2005 Q1 | -20 Thousand USD | -109.9% |
| 2005 Q2 | 430 Thousand USD | 2250.0% |
| 2005 Q3 | 879 Thousand USD | 104.42% |
| 2005 Q4 | 382 Thousand USD | -56.54% |
| 2005 FY | 1.67 Million USD | 515.67% |
| 2004 FY | -402 Thousand USD | -208.36% |
| 2004 Q4 | 202 Thousand USD | 128.06% |
| 2004 Q3 | -720 Thousand USD | -641.35% |
| 2004 Q2 | 133 Thousand USD | 882.35% |
| 2004 Q1 | -17 Thousand USD | -103.46% |
| 2003 Q1 | -82 Thousand USD | -113.71% |
| 2003 Q3 | 261 Thousand USD | 187.29% |
| 2003 Q4 | 491 Thousand USD | 88.12% |
| 2003 Q2 | -299 Thousand USD | -264.63% |
| 2003 FY | 371 Thousand USD | 147.33% |
| 2002 Q2 | -447 Thousand USD | -115.94% |
| 2002 Q1 | -207 Thousand USD | -157.02% |
| 2002 FY | 150 Thousand USD | 111.78% |
| 2002 Q4 | 598 Thousand USD | 190.29% |
| 2002 Q3 | 206 Thousand USD | 146.09% |
| 2001 Q4 | 363 Thousand USD | 112.28% |
| 2001 Q3 | 171 Thousand USD | 1454.55% |
| 2001 Q2 | 11 Thousand USD | 100.61% |
| 2001 Q1 | -1.81 Million USD | -524.53% |
| 2001 FY | -1.27 Million USD | -152.69% |
| 2000 FY | 2.41 Million USD | 49.32% |
| 2000 Q4 | 428 Thousand USD | -23.71% |
| 2000 Q3 | 561 Thousand USD | -21.65% |
| 2000 Q2 | 716 Thousand USD | 0.7% |
| 2000 Q1 | 711 Thousand USD | -13.08% |
| 1999 Q1 | 200 Thousand USD | -60.0% |
| 1999 FY | 1.61 Million USD | -4.82% |
| 1999 Q4 | 818 Thousand USD | 172.67% |
| 1999 Q3 | 300 Thousand USD | 0.0% |
| 1999 Q2 | 300 Thousand USD | 50.0% |
| 1998 FY | 1.7 Million USD | -19.05% |
| 1998 Q4 | 500 Thousand USD | 0.0% |
| 1998 Q3 | - USD | -100.0% |
| 1998 Q2 | 500 Thousand USD | -28.57% |
| 1998 Q1 | 700 Thousand USD | -12.5% |
| 1997 Q4 | 800 Thousand USD | 33.33% |
| 1997 FY | 2.1 Million USD | 110.0% |
| 1997 Q2 | 500 Thousand USD | 150.0% |
| 1997 Q1 | 200 Thousand USD | -50.0% |
| 1997 Q3 | 600 Thousand USD | 20.0% |
| 1996 FY | 1 Million USD | 0.0% |
| 1996 Q1 | 200 Thousand USD | -50.0% |
| 1996 Q2 | 200 Thousand USD | 0.0% |
| 1996 Q3 | 200 Thousand USD | 0.0% |
| 1996 Q4 | 400 Thousand USD | 100.0% |
| 1995 FY | 1 Million USD | 0.0% |
| 1995 Q3 | 200 Thousand USD | 0.0% |
| 1995 Q4 | 400 Thousand USD | 100.0% |
| 1995 Q1 | 200 Thousand USD | 0.0% |
| 1995 Q2 | 200 Thousand USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | -61.61 Million USD | 84.469% |
| BrainsWay Ltd. | -4.19 Million USD | -128.02% |
| Cerus Corporation | -37.48 Million USD | 74.473% |
| Envoy Medical, Inc. | -29.9 Million USD | 68.002% |
| electroCore, Inc. | -18.83 Million USD | 49.188% |
| Helius Medical Technologies, Inc. | -8.85 Million USD | -8.136% |
| IceCure Medical Ltd | -14.65 Million USD | 34.685% |
| Inogen, Inc. | -102.44 Million USD | 90.659% |
| OrthoPediatrics Corp. | -20.97 Million USD | 54.372% |
| Lucid Diagnostics Inc. | -52.66 Million USD | 81.829% |
| Monogram Orthopaedics, Inc. | -13.74 Million USD | 30.376% |
| MaxCyte, Inc. | -37.92 Million USD | 74.765% |
| NeuroOne Medical Technologies Corporation | -11.85 Million USD | 19.305% |
| Nexalin Technology, Inc. | -4.64 Million USD | -105.864% |
| Orthofix Medical Inc. | -151.39 Million USD | 93.679% |
| PAVmed Inc | -64.17 Million USD | 85.088% |
| Rapid Micro Biosystems, Inc. | -52.46 Million USD | 81.76% |
| RxSight, Inc. | -48.6 Million USD | 80.312% |
| Sight Sciences, Inc. | -55.54 Million USD | 82.771% |
| SI-BONE, Inc. | -43.33 Million USD | 77.917% |
| TELA Bio, Inc. | -46.66 Million USD | 79.492% |
| Treace Medical Concepts, Inc. | -49.52 Million USD | 80.677% |
| Vivos Therapeutics, Inc. | -13.58 Million USD | 29.544% |
| Acutus Medical, Inc. | -81.66 Million USD | 88.281% |
| Talis Biomedical Corporation | -62 Million USD | 84.566% |
| Spectral AI, Inc. | -20.85 Million USD | 54.11% |
| Nano-X Imaging Ltd. | -60.77 Million USD | 84.254% |
| CVRx, Inc. | -41.19 Million USD | 76.771% |
| DIH Holding US, Inc. Warrants | 640.19 Thousand USD | 1594.855% |
| PetVivo Holdings, Inc. | -10.95 Million USD | 12.645% |
| Bioventus Inc. | -156.23 Million USD | 93.874% |
| Venus Concept Inc. | -37.25 Million USD | 74.309% |
| TriSalus Life Sciences, Inc. | -59.03 Million USD | 83.79% |
| LivaNova PLC | 17.54 Million USD | 154.542% |
| 908 Devices Inc. | -36.39 Million USD | 73.708% |
| Alphatec Holdings, Inc. | -186.63 Million USD | 94.872% |
| Nemaura Medical Inc. | -14.14 Million USD | 32.338% |
| NeuroPace, Inc. | -32.95 Million USD | 70.961% |
| LENSAR, Inc. | -14.38 Million USD | 33.463% |
| Apyx Medical Corporation | -18.71 Million USD | 48.859% |
| Cutera, Inc. | -162.83 Million USD | 94.123% |
| STRATA Skin Sciences, Inc. | -10.83 Million USD | 11.634% |
| BioSig Technologies, Inc. | -29.04 Million USD | 67.047% |
| Anika Therapeutics, Inc. | -82.66 Million USD | 88.423% |
| ClearPoint Neuro, Inc. | -22.08 Million USD | 56.675% |
| Integra LifeSciences Holdings Corporation | 67.74 Million USD | 114.127% |
| Axonics, Inc. | -6.08 Million USD | -57.194% |
| Outset Medical, Inc. | -172.79 Million USD | 94.462% |
| PROCEPT BioRobotics Corporation | -105.89 Million USD | 90.963% |
| IRadimed Corporation | 17.19 Million USD | 155.663% |
| Tivic Health Systems, Inc. | -8.24 Million USD | -16.084% |
| INVO Bioscience, Inc. | -8.03 Million USD | -19.11% |
| Telesis Bio, Inc. | -47.72 Million USD | 79.947% |
| Viemed Healthcare, Inc. | 10.24 Million USD | 193.43% |
| Varex Imaging Corporation | -47.7 Million USD | 79.937% |
| Quipt Home Medical Corp. | -2.78 Million USD | -243.75% |
| Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | 15.205% |
| Pulmonx Corporation | -60.84 Million USD | 84.271% |
| Dynatronics Corporation | -2.69 Million USD | -254.744% |
| Modular Medical, Inc. | -17.47 Million USD | 45.22% |
| ReShape Lifesciences Inc. | -11.38 Million USD | 15.957% |
| Semler Scientific, Inc. | 20.58 Million USD | 146.495% |
| InMode Ltd. | 197.91 Million USD | 104.835% |
| Bruker Corporation | 427.2 Million USD | 102.24% |
| Cytosorbents Corporation | -28.5 Million USD | 66.43% |
| DexCom, Inc. | 541.5 Million USD | 101.767% |
| Align Technology, Inc. | 445.05 Million USD | 102.15% |
| Viveve Medical, Inc. | -22.02 Million USD | 56.553% |
| ZimVie Inc. | -393.28 Million USD | 97.567% |
| Movano Inc. | -29.28 Million USD | 67.319% |
| Cytek Biosciences, Inc. | -12.14 Million USD | 21.222% |
| Nexalin Technology, Inc. | -4.64 Million USD | -105.864% |
| DIH Holdings US, Inc. Class A Common Stock | 640.19 Thousand USD | 1594.855% |
| Tandem Diabetes Care, Inc. | -222.61 Million USD | 95.701% |
| Profound Medical Corp. | -28.56 Million USD | 66.502% |
| Insulet Corporation | 206.3 Million USD | 104.639% |
| enVVeno Medical Corporation | -23.51 Million USD | 59.304% |
| Surmodics, Inc. | -11.54 Million USD | 17.085% |
| iCAD, Inc. | -4.84 Million USD | -97.442% |
| Nuwellis, Inc. | -20.2 Million USD | 52.645% |
| Biotricity, Inc. | -14.09 Million USD | 32.1% |
| iRhythm Technologies, Inc. | -123.4 Million USD | 92.245% |
| Aethlon Medical, Inc. | -12.2 Million USD | 21.61% |
| InspireMD, Inc. | -19.91 Million USD | 51.948% |
| PAVmed Inc. | -64.17 Million USD | 85.088% |
| BIOLASE, Inc. | -20.63 Million USD | 53.616% |
| Beyond Air, Inc. | -60.24 Million USD | 84.114% |
| FONAR Corporation | 10.56 Million USD | 190.562% |
| AxoGen, Inc. | -21.71 Million USD | 55.931% |
| Vivani Medical, Inc. | -25.65 Million USD | 62.693% |
| Tactile Systems Technology, Inc. | 28.51 Million USD | 133.561% |
| Inari Medical, Inc. | -1.63 Million USD | -484.963% |
| UFP Technologies, Inc. | 44.92 Million USD | 121.303% |
| QT Imaging Holdings, Inc. | -5.13 Million USD | -86.465% |
| Heart Test Laboratories, Inc. | -6.6 Million USD | -44.886% |
| Tenon Medical, Inc. | -15.58 Million USD | 38.579% |
| Autonomix Medical, Inc. Common Stock | -15.42 Million USD | 37.962% |
| Co-Diagnostics, Inc. | -35.33 Million USD | 72.915% |
| AdaptHealth Corp. | -678.89 Million USD | 98.59% |
| Sintx Technologies, Inc. | -8.25 Million USD | -15.874% |
| NanoVibronix, Inc. | -3.71 Million USD | -157.882% |
| Quanterix Corporation | -32.33 Million USD | 70.403% |
| Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | 15.205% |
| Sensus Healthcare, Inc. | 485 Thousand USD | 2073.196% |
| Pacific Biosciences of California, Inc. | -306.73 Million USD | 96.88% |
| TransMedics Group, Inc. | -25.02 Million USD | 61.763% |
| ReWalk Robotics Ltd. | -22.13 Million USD | 56.761% |
| NeuroMetrix, Inc. | -6.52 Million USD | -46.566% |
| Hyperfine, Inc. | -44.23 Million USD | 78.367% |
| Establishment Labs Holdings Inc. | -78.5 Million USD | 87.809% |
| Biomerica, Inc. | -5.97 Million USD | -60.087% |
| Bone Biologics Corporation | -8.94 Million USD | -6.943% |
| AVITA Medical, Inc. | -39.16 Million USD | 75.567% |
| Bluejay Diagnostics, Inc. | -9.95 Million USD | 3.857% |
| Silk Road Medical, Inc | -55.74 Million USD | 82.832% |